Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Analysis of the Resistance Profile of Real-World Alectinib First-Line Therapy in Patients with ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer Using Organoid Technology in One Case of Lung Cancer

Yingbo Xie, Yuxin Zhang,Xiaohong Xie,Xinqing Lin,Qing Tang,Chengzhi Zhou,Zhanhong Xie

Journal of Thoracic Disease（2024）

Cited 0|Views0
Key words
Alectinib,anaplastic lymphoma kinase (ALK),ALK ),drug sensitivity testing,non-small cell lung cancer (NSCLC),organoid
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined